Serpentine Supravenous Hyperpigmentation Following Intravenous Docetaxel

• Autors principals: Satarupa Mondal (Autor), Avik Panigrahi (Autor), Dibyendu Bikash Bhanja (Autor), Sayantani Chakraborty (Autor), Abheek Sil (Autor)
• Format: Llibre
• Publicat: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Serpentine supravenous hyperpigmentation is a rare, cutaneous sequela of intravenous chemotherapeutic agents, collagen vascular diseases (systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), and infections like leprosy and HIV. The condition manifests clinically as a peculiar...